Shifting perspectives in liver diseases after kidney transplantation

doi:10.4254/wjh.v15.i7.883

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4379)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

WORD

110

HTML

2421

Figures (1-1)

238

Tables (1-1)

182

Sum=3033

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

165

Download

525

Sum=690

Publishing Process of This Article

Item

Count

Browse

144

Download

326

Sum=470

Jul 27, 2023 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Jul 27, 2023; 15(7): 883-896
Published online Jul 27, 2023. doi: 10.4254/wjh.v15.i7.883

Open in New Tab Full Size Figure Download Figure

Figure 1 Progress achieved to date and high priority topics in four main types of liver diseases affecting patients after kidney transplantation. NAFLD: Non-alcoholic fatty liver disease; CNIs: Calcineurin inhibitors; DAAs: Direct acting antivirals; HCV D+/R-: Hepatits C virus donor positive/recipient negative; COVID-19: Coronavirus disease 2019; HEV: Hepatitis E virus; DILI: Drug induced liver injury; V2R: Vasopresin receptor 2; KT: Kidney transplantation; ADPKD: Autosomal dominant polycystic kidney disease.

Citation: Kosuta I, Ostojic A, Vujaklija Brajkovic A, Babel J, Simunov B, Sremac M, Mrzljak A. Shifting perspectives in liver diseases after kidney transplantation. World J Hepatol 2023; 15(7): 883-896
URL: https://www.wjgnet.com/1948-5182/full/v15/i7/883.htm
DOI: https://dx.doi.org/10.4254/wjh.v15.i7.883